Karolinska Development Appoints New Chief Financial Officer
News Jan 30, 2014
Karolinska Development has announced that Christian Tange has accepted the role of Chief Financial Officer. He will succeed Robin Wright, who will be leaving the company at the end of February, following the audit and report of the 2013 annual results.
Christian Tange (b. 1966) has over 15 years’ experience in international growth companies. In recent years, he has acted as an industrial advisor and consultant for Private Equity funds and Corporate Finance advisors in M&A deals within life science.
During the period 2003-2012 he worked as global CFO of CMC Biologics, an international biotech contract manufacturing company. Christian holds a Masters degree in Economics and Law from Copenhagen Business School. He will start working with Karolinska Development from February 1, 2014 and take on the CFO role on March 1, 2014.
"After many years of working in Sweden, Robin Wright has decided to leave Karolinska Development to take up a new role in the UK to be nearer to his family. We understand and respect his decision and we thank him for his significant contributions to the company’s progress. At the same time, it is a pleasure to welcome Christian Tange to the CFO position. Christian has a strong track record as CFO and his experience in healthcare M&A and business development matches perfectly with Karolinska Development’s current focus. I am looking forward to working with him in future deals", says Torbjörn Bjerke, CEO of Karolinska Development.
Smart Phone Developed for Quicker Infection TestingNews
Washington State University researchers have developed a low-cost, portable laboratory on a phone that works nearly as well as clinical laboratories to detect common viral and bacterial infections.READ MORE
New Rapid-fire Method Using Pathology Images & Tumor Data May Help Guide Cancer TherapiesNews
By combining data on pathology images of 13 types of cancer and correlating that with clinical and genomic data, researchers are able to identify tumor-infiltrating lymphocytes, which will enable cancer specialists to generate tumor-immune information from routinely gathered pathology slides.READ MORE
Comments | 0 ADD COMMENT
6th International Conference on Neurodegenerative Disorders and Stroke
Oct 22 - Oct 23, 2018
16th Annual Conference on Laboratory Medicine and Pathology
Sep 17 - Sep 18, 2018